Michael Wallace

Venture Partner at ShangBay Capital

Mike is a medical device executive and serial entrepreneur with over 25 years of experience, inventor of over 130 issued U.S patents, and a passion for purposeful innovation to help patients. Mike holds a BSME from the University of Delaware and a Masters In Mechanical Engineering from UC Davis.

He is currently the CEO and Co-founder of his 4th startup, DeVoro Medical. DeVoro is focused on disrupting the growing peripheral thrombectomy space with its novel WOLF thrombectomy platform.

Mike has also been fortunate to be part of 3 other successful startup exits that he Co-founded: TW Medical - a neurovascular intra aneurysmal solution acquired by Stryker, GW Medical Neuro WOLF Solution- acquired by Stryker and CardioProlific – a Peripheral Vascular solutions company acquired by Philips.

Location

San Francisco, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


ShangBay Capital

ShangBay Capital is a venture capital company that brings both U.S. and Chinese investors access to best-in-class investments in the U.S. medical devices technology, biotechnology, and mobile healthcare sectors through early-stage venture equity participation.


Industries

Employees

1-10

Links